Day # 170: Caffeine Use Disorder

Today's Content Level: Intermediate

Introduction 1, 2

Intro

• Caffeine is the most widely used psychoactive substance in the world.

• It is legal, socially endorsed, and many people rely on it daily to boost alertness, energy, and even mood. Yet, for some, caffeine use crosses from casual enjoyment into a pattern that causes significant symptoms or impairment.

• Caffeine can absolutely meet criteria for a substance use disorder. DSM-5 stopped short of fully endorsing Caffeine Use Disorder as a formal diagnosis, but it’s listed in Section III (“conditions for further study”).

• Understanding this disorder is crucial for recognizing when caffeine consumption becomes problematic and how to manage it effectively.

Mechanism of Action

• Caffeine’s primary mechanism is adenosine receptor antagonism (A1 and A2A receptors).

• Adenosine triphosphate (ATP) is the the primary energy currency of cells. Throughout the day, ATP breakdown leads to an accumulation of adenosine in the brain, which binds to receptors to promote sleepiness and relaxation. Caffeine works by blocking these receptors, preventing you from feeling tired.

• Key downstream effects:

  • ↓ Adenosine receptor binding → ↓ sleep pressure

  • ↑ Dopamine signaling (indirectly)

  • ↑ Norepinephrine and epinephrine release

  • ↑ Cortisol

  • ↑ Sympathetic tone

• Secondary effects:

  • Mild phosphodiesterase inhibition

  • Increased intracellular calcium

• Net effect:

  • Alertness, stimulation, and anxiety that is dose dependent.

• Importantly, tolerance develops quickly, which drives escalating intake and sets the stage for withdrawal and dependence.

Diagnostic Criteria 3

• Caffeine Use Disorder is not officially recognized in all diagnostic manuals but is increasingly acknowledged in clinical research. The same clinical criteria used in the DSM-5 substance use disorder section can be used.

• Diagnostic criteria for all substance use disorders are the same, characterized by a ≥ 12-month period of problematic substance use that leads to impairment or distress and requires ≥2 additional criteria. See Day #160: Introduction to Substance Use Disorders for complete diagnostic criteria and severity specifiers.

Epidemiology & Pathogenesis 4, 5

• ~85–90% of adults consume caffeine daily

• Average adult intake: ~100-200 mg/day, however >400 mg/day is not uncommon and often under-recognized.

• Caffeine can be functional and beneficial at low doses, enhancing alertness and productivity.

• While low to moderate consumption is generally safe, higher doses can pose health risks, especially for vulnerable individuals, leading to cardiovascular issues, perinatal complications, or dependence.

• High doses cause negative side effects, making caffeine use typically self-limiting.

• Although widespread and socially acceptable, caffeine can lead to pathological symptoms or behaviors similar to those from alcohol or drugs, with some individuals becoming dependent.

• The prevalence and severity of caffeine dependence remain unclear.

• Risk factors that drive higher consumption and increase risk of developing dependence:

  • Insomnia

  • Shift work / sleep deprivation

  • ADHD ("self-medication")

  • High occupational demands

  • Cultural normalization

• Pathogenesis:

  • Repeated adenosine blockade → receptor upregulation

  • Neuroadaptation → tolerance

  • Abrupt cessation → unopposed adenosine activity → withdrawal

Psychopoly (Psychology Board Game)

Clinical Pearls 6

General SUD History

• Obtain a detailed history (onset, frequency, quantity, last use, forms and routes), prior treatment attempts, periods of sobriety, withdrawal symptoms, impact on daily functioning, social history with triggers, and co-occurring psychiatric or medical conditions. Ask DSM-5 symptoms of SUD (loss of control, craving, risky use, tolerance, withdrawal, impairment).

Caffeine Specific Pearls

• If you don’t ask about caffeine, you will miss it. Patients routinely underestimate caffeine intake.

• “I don’t drink coffee” ≠ “I don’t use caffeine.” Energy drinks + coffee + pre-workout + soda = problems

• In practice, caffeine use disorder can show up as anxiety, insomnia, palpitations, GI distress, headaches, and a surprising amount of functional impairment.

• Screening for caffeine use should be part of the assessment in patients presenting with anxiety, sleep problems, or unexplained physical symptoms like palpitations.

• Caffeine use disorder can mimic anxiety disorders due to overlapping symptoms. Patients may not recognize caffeine as the cause of their symptoms because it is socially accepted and widely consumed.

• Anxiety, panic, and insomnia can improve dramatically with caffeine reduction.

• Headaches that “only respond to caffeine” are often caffeine-withdrawal headaches.

Common sources of caffeine organized in descending order by caffeine content

• Pre-workout supplements: ~200–400+ mg per serving; often multiple stimulants; labeling may be inaccurate.

• Energy drinks (large can, 16–24 oz): ~150–300 mg

• Cold brew coffee (16 oz): ~200–300 mg

• Brewed coffee (12–16 oz): ~120–200 mg; highly variable based on bean, roast, and preparation.

• Espresso (2 shots): ~120–150 mg; lower volume & higher concentration → easy to underestimate.

• Caffeinated soda (20 oz): ~50–70 mg

• Black tea (8–12 oz): ~40–70 mg

• Green tea (8–12 oz): ~25–45 mg

• Chocolate / cocoa products: ~5–30 mg per serving

Dosing recommendations

• General adult recommendation: ≤ 400 mg/day. This is the most commonly cited upper limit and is considered safe for most healthy adults.

• Important caveats:

  • Clinically, “safe” and “well-tolerated” are not the same thing.

  • Many patients develop clinically significant anxiety, insomnia, or palpitations well below 400 mg.

  • Pregnant patients: ≤ 200 mg/day

  • Patients with anxiety disorders, insomnia, arrhythmias, or GERD often need much lower limits.

Timing recommendations

• Rule of thumb: avoid caffeine within 8 hours of bedtime.

• Caffeine half-life averages 5–7 hours, meaning ~25–50% may still be active at bedtime.

• Sleep onset can appear “normal” while sleep quality is still impaired.

• More conservative (and often more effective): avoid caffeine after noon.

How I advise patients

• Try to stick to ≤ 200 mg/day

• Consume only in the morning, last caffeine use before noon

• Treat caffeine like a medication with a half-life, not a beverage

• If anxiety, sleep-onset insomnia, early awakenings, or fragmented sleep are issues, caffeine reduction is worth trying before adding another prescription or other treatments.

Intoxication

Symptoms

• Restlessness, nervousness

• Insomnia

• Tremor or muscle twitching

• Tachycardia / palpitations

• GI upset

• Anxiety or panic attacks

• Diuresis

• Headache

• In severe cases: agitation, arrhythmias, confusion, psychosis, seizures

Treatment of Intoxication

• Stop caffeine intake immediately

• Supportive care, reassurance, provide a calm quiet environment to reduce agitation

• Hydration to support metabolism and excretion

• Short-term beta-blockers may help somatic anxiety. Benzodiazepines may be used to manage severe agitation or seizures.

• Most cases resolve with time and caffeine reduction.

Withdrawal

Symptoms:

• Symptoms typically begin 12–24 hours after cessation

• Headache (most common)

• Fatigue and sleepiness

• Decreased alertness

• Depressed mood

• Irritability or anxiety

• Flu-like symptoms (myalgias, nausea)

• Peak: 24–48 hours

• Duration: 2–9 days

Treatment:

• Gradual taper over days to weeks rather than abrupt cessation

• NSAIDs or acetaminophen for headaches

• Hydration

• Sleep normalization

• Encouraging alternative ways to boost energy such as light exercise and good sleep hygiene.

• Reassurance ("this will pass"). Psychological support or counseling if mood symptoms are significant.

Treatment of Caffeine Use Disorder 7

• Treatment aims to reduce caffeine intake to a level that does not cause distress or impairment or to achieve abstinence if necessary.

• There is no FDA-approved medication for caffeine use disorder.

• Psychoeducation: Informing patients about caffeine’s effects, risks, and withdrawal symptoms.

• Gradual taper: Quantify total daily caffeine intake and then create a plan to gradually taper (e.g., reduce by 25–50 mg every few days)

• Replace behavioral rituals (decaf, tea, non-caffeinated routines)

• Address underlying drivers:

  • Insomnia

  • Anxiety

  • Work schedule

  • ADHD

  • CBT-I and anxiety-focused interventions are often more effective than focusing on caffeine alone.

• General SUD treatment: Individual and/or group therapy should be part of every SUD treatment approach. See Day 60: Intro to SUD for a discussion of interventions that include behavioral therapies, peer support & 12-step programs, and family support resources.

Conclusion

• Low to moderate doses of caffeine is generally safe, but consumption of higher doses by vulnerable individuals can lead to increased risk of dependence, withdrawal, neurobiological consequences, and risk of functional decline. Caffeine use disorder is underrecognized. We need to ask about it, measure it, and treat it when present.

Resources for today's post include:

• DSM-5-TR

• Articles referenced above

See our full list of book recommendations for the most up-to-date editions.

If you enjoy this content and would like to support the website then consider donating.

Bullet Psych is an Amazon.com affiliate.